Commonwealth Equity Services, Inc - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 74 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.2%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2017$13,000
-18.8%
30,587
-4.7%
0.00%
Q2 2017$16,000
-20.0%
32,087
-5.9%
0.00%
Q1 2017$20,000
-9.1%
34,0870.0%0.00%
Q4 2016$22,000
-29.0%
34,0870.0%0.00%
Q3 2016$31,000
+72.2%
34,0870.0%0.00%
Q2 2016$18,000
-45.5%
34,087
-2.1%
0.00%
Q1 2016$33,000
-28.3%
34,8020.0%0.00%
Q4 2015$46,000
-43.9%
34,802
-2.8%
0.00%
-100.0%
Q3 2015$82,000
+34.4%
35,802
-5.3%
0.00%0.0%
Q2 2015$61,000
+1.7%
37,8020.0%0.00%0.0%
Q1 2015$60,000
-15.5%
37,8020.0%0.00%0.0%
Q4 2014$71,000
+34.0%
37,802
-5.0%
0.00%0.0%
Q3 2014$53,000
-14.5%
39,802
-4.8%
0.00%0.0%
Q2 2014$62,000
-16.2%
41,814
+4.3%
0.00%0.0%
Q1 2014$74,000
-7.5%
40,099
+3.9%
0.00%0.0%
Q4 2013$80,000
-13.0%
38,599
+10.6%
0.00%0.0%
Q3 2013$92,000
+4.5%
34,884
+6.1%
0.00%
-50.0%
Q2 2013$88,00032,8840.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q1 2016
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 10,375,329$13,549,00019.76%
Catalyst Capital Advisors LLC 790,000$1,635,0000.53%
DSC Advisors, L.P. 500,000$1,035,0000.50%
STONERIDGE INVESTMENT PARTNERS LLC 142,528$295,0000.06%
Hudock, Inc. 30,500$63,0000.05%
BRR OpCo, LLC 52,700$109,0000.05%
TFS CAPITAL LLC 418,074$865,0000.04%
LifePlan Financial Group, Inc 28,810$60,0000.04%
NOMURA HOLDINGS INC 3,831,177$7,947,0000.04%
BOLTON LP 77,400$160,0000.03%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders